---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-015488"
form_type: "8-K"
ticker: "VTAK"
cik: "0001716621"
company_name: "Catheter Precision, Inc."
filed_at: "2025-05-08T23:59:59+00:00"
generated_at: "2026-05-22T04:56:05.927143+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Catheter Precision subsidiary acquires Cardionomic's heart failure assets for 1M shares and $1.5M note

## Summary
- Cardionomix purchased CNPS System patents/trademarks for heart failure; closed May 5, 2025.
- Consideration: 1M restricted VTAK shares and $1.5M note at 4% due May 2028.
- Cardionomix minority stakes: CEO Jenkins (5%), FatBoy Capital (7%), others; requires development financing.
- Company seeking additional financing including ATM offering; warns of dilution.
- Assets acquired 'AS IS'; Cardionomix has no other significant assets.

## SEC filing metadata
- accession: 0001437749-25-015488
- form_type: 8-K
- ticker: VTAK
- cik: 0001716621
- company_name: Catheter Precision, Inc.
- filed_at: 2025-05-08T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 2.03, 2.01, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1716621/000143774925015488/0001437749-25-015488-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1716621/000143774925015488/vtak20250507_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-015488
- JSON: https://secwatch.observer/filing/0001437749-25-015488.json
- Plain text: https://secwatch.observer/filing/0001437749-25-015488.txt

## Key facts
- Debt Financings
  Catheter Precision, Inc. incurred loan of $1.5 million with Cardionomic (assignment for the benefit of creditors), LLC at 4% per annum maturing May 5, 2028.
  - Instrument: loan
  - Principal: $1.5 million
  - Counterparty: Cardionomic (assignment for the benefit of creditors), LLC
  - Rate: 4% per annum
  - Maturity: May 5, 2028
  - Event: incurrence
  source text: the issuance by Cardionomix of a promissory note (the "Note") in the amount of $1.5 million, with simple interest accruing at 4% per annum on the principal thereof and no interest or principal payable until the maturity date of the Note, which will be May 5, 2028
  evidence_url: https://www.sec.gov/Archives/edgar/data/1716621/000143774925015488/0001437749-25-015488-index.htm
- M&A Transactions
  Catheter Precision, Inc. completed an acquisition involving Cardionomic (assignment for the benefit of creditors), LLC for 1,000,000 restricted shares of the Company's common stock and a promissory note in the amount of $1.5 million (closed 2025-05-05).
  - Action: acquisition
  - Counterparty: Cardionomic (assignment for the benefit of creditors), LLC
  - Consideration: 1,000,000 restricted shares of the Company's common stock and a promissory note in the amount of $1.5 million
  - Closing: 2025-05-05
  source text: or warranties as to merchantability, fitness or use from Seller and no representations from or privity with Assignor, in exchange for the issuance by the Company of 1,000,000 restricted shares of the Company's common stock, $0.0001 par value per share (the “Share Consideration”) and the issuance by Cardionomix of a promissory note (the "Note") in the
  evidence_url: https://www.sec.gov/Archives/edgar/data/1716621/000143774925015488/0001437749-25-015488-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.